For Healthcare Professionals Only

Important Safety InformationPrescribing Information
Important Safety InformationPrescribing Information
header pattern

References

swooshesswooshes
  1. Data on file. Harrow IP, LLC; 2023.
  2. Iheezo. Prescribing information. Harrow IP, LLC; 2022.
  3. Shah HR, Reichel E, Busbee BG. A novel lidocaine hydrochloride ophthalmic gel for topical ocular anesthesia. Local Reg Anesth. 2010;3:57-63.
  4. Rinella Han J, Rinella NT, Chao DL. Anesthesia for intravitreal injection: a systematic review. Clin Ophthalmol. 2020;14:543-550.
  5. Sintetica. Chloroprocaine hydrochloride ophthalmic gel 3%. Pharmaceutical Development. Sintetica; 2002.
  6. Akten. Material safety data sheet. Akorn Pharmaceuticals; 2010.
  7. Ilyas H, Costine R. The Effects of Low Viscosity Preservative-Free Chloroprocaine Ophthalmic Gel 3% versus BAK-Containing Tetracaine 0.5% on the Bactericidal Action of Povidone-Iodine. Clin Ophthalmol. 2024;18:825-831 https://doi.org/10.2147/OPTH.S454496.
  8. Intravitreal Injections. The Foundation of the American Society of Retina Specialists. Accessed October 30, 2022. https://www.asrs.org/content/documents/fact-sheet-30-intravitreal-injections.pdf.

Approved Use

IHEEZO® is indicated for ocular surface anesthesia.

Important Safety Information

IHEEZO is contraindicated in patients with a history of hypersensitivity to any component of this preparation.

Approved Use

IHEEZO® is indicated for ocular surface anesthesia.

Important Safety Information

IHEEZO is contraindicated in patients with a history of hypersensitivity to any component of this preparation.

Approved Use

IHEEZO® is indicated for ocular surface anesthesia.

Important Safety Information

  • IHEEZO is contraindicated in patients with a history of hypersensitivity to any component of this preparation.
  • IHEEZO should not be injected or intraocularly administered.
  • Patients should not touch the eye for at least 10 to 20 minutes after using anesthetic as accidental injuries can occur due to insensitivity of the eye.
  • Prolonged use of a topical ocular anesthetic may produce permanent corneal opacification and ulceration with accompanying visual loss.
  • Do not touch the dropper tip to any surface as this may contaminate the gel.
  • IHEEZO is indicated for administration under the direct supervision of a healthcare provider. IHEEZO is not intended for patient self-administration.
  • The most common adverse reactions in studies following IHEEZO administration (incidence greater than or equal to 5%) were mydriasis, conjunctival hyperemia, and eye irritation.
  • You are encouraged to report suspected adverse reactions to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
  • For additional information about IHEEZO, please see the full Prescribing Information.

Approved Use

IHEEZO® is indicated for ocular surface anesthesia.

Important Safety Information

  • IHEEZO is contraindicated in patients with a history of hypersensitivity to any component of this preparation.
  • IHEEZO should not be injected or intraocularly administered.
  • Patients should not touch the eye for at least 10 to 20 minutes after using anesthetic as accidental injuries can occur due to insensitivity of the eye.
  • Prolonged use of a topical ocular anesthetic may produce permanent corneal opacification and ulceration with accompanying visual loss.
  • Do not touch the dropper tip to any surface as this may contaminate the gel.
  • IHEEZO is indicated for administration under the direct supervision of a healthcare provider. IHEEZO is not intended for patient self-administration.
  • The most common adverse reactions in studies following IHEEZO administration (incidence greater than or equal to 5%) were mydriasis, conjunctival hyperemia, and eye irritation.
  • You are encouraged to report suspected adverse reactions to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
  • For additional information about IHEEZO, please see the full Prescribing Information.

By clicking “Allow All”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.